NCT06830850
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06830850
Title A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Atridia Pty Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
GenesisCare North Shore (Oncology) Sydney New South Wales Australia Details
Sydney Adventist Hospital Sydney New South Wales Australia Details
Cancer Research SA Adelaide South Australia Australia Details
Southern Oncology Clinical Research Unit Adelaide South Australia Australia Details
Icon Cancer Centre South Brisbane Brisbane Australia Details
John Flynn Private Hospital Brisbane Australia Details
Eastern Health (Box Hill Hospital) Melbourne Australia Details
Linear Clinical Research Ltd Perth Australia Details
Macquarie University Sydney Australia Details
MUPharm Pty Limited trading as Macquarie University Hospital Pharmacy Sydney Australia Details
Illawarra Shoalhaven Local Health District (Wollongong Hospital) Wollongong Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field